4528 Stock Overview
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Ono Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,262.00 |
| 52 Week High | JP¥2,966.50 |
| 52 Week Low | JP¥2,097.50 |
| Beta | 0.18 |
| 11 Month Change | 1.46% |
| 3 Month Change | -1.65% |
| 1 Year Change | -13.22% |
| 33 Year Change | -8.99% |
| 5 Year Change | 12.26% |
| Change since IPO | 83.90% |
Recent News & Updates
Shareholder Returns
| 4528 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -0.09% | -1.0% | -5.2% |
| 1Y | -13.2% | 15.8% | 15.7% |
Return vs Industry: 4528 underperformed the JP Pharmaceuticals industry which returned 15.8% over the past year.
Return vs Market: 4528 underperformed the JP Market which returned 15.7% over the past year.
Price Volatility
| 4528 volatility | |
|---|---|
| 4528 Average Weekly Movement | 2.8% |
| Pharmaceuticals Industry Average Movement | 4.0% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 1.8% |
Stable Share Price: 4528 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4528's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1717 | 3,853 | Gyo Sagara | www.ono-pharma.com |
Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia. The company also provides Glactiv tablets for type 2 diabetes; Forxiga tablets for diabetes; Onoact Intravenous Infusion for tachyarrhythmia; Opalmon tablets to treat peripheral circulatory disorder; Coralan for chronic heart failure; Orencia injections for rheumatoid arthritis; Rivastach patches for Alzheimer’s disease; Ongentys tablets for Parkinson’s disease; Parsabiv, an intravenous infusion for dialysis patients; Staybla tablets for overactive bladder; Onon capsules and Dry Syrups for bronchial asthma and allergic rhinitis; and JOYCLU intra-articular injection for the improvement of joint function, as well as Recalbon tablets for osteoporosis.
Ono Pharmaceutical Co., Ltd. Fundamentals Summary
| 4528 fundamental statistics | |
|---|---|
| Market cap | JP¥1.06t |
| Earnings (TTM) | JP¥127.98b |
| Revenue (TTM) | JP¥502.67b |
8.3x
P/E Ratio2.1x
P/S RatioIs 4528 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4528 income statement (TTM) | |
|---|---|
| Revenue | JP¥502.67b |
| Cost of Revenue | JP¥127.13b |
| Gross Profit | JP¥375.55b |
| Other Expenses | JP¥247.57b |
| Earnings | JP¥127.98b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 31, 2024
| Earnings per share (EPS) | 272.50 |
| Gross Margin | 74.71% |
| Net Profit Margin | 25.46% |
| Debt/Equity Ratio | 0% |
How did 4528 perform over the long term?
See historical performance and comparisonDividends
3.5%
Current Dividend Yield30%
Payout RatioDoes 4528 pay a reliable dividends?
See 4528 dividend history and benchmarks| Ono Pharmaceutical dividend dates | |
|---|---|
| Ex Dividend Date | Sep 27 2024 |
| Dividend Pay Date | Dec 02 2024 |
| Days until Ex dividend | 62 days |
| Days until Dividend pay date | 128 days |
Does 4528 pay a reliable dividends?
See 4528 dividend history and benchmarks